Capnocytophaga, one of the genera of oral bacteria, has been implicated in the pathogenesis of several diseases, including endocarditis, septicaemia and disorders of the oral cavity such as abscesses and periodontal disease. This study examined sonic extracts (SE) of Capnocytophaga strains for their ability to alter lymphocyte function. The SE of tested Capnocytophaga caused dose-dependent suppression of spleen cells in response to mitogen. This suppressive effect was heat-labile and sensitive to the proteolytic enzyme pronase E. The suppressive factor (SF) was purified from SE of C. ochrasea by a combination of ultrogel-AcA34, high-pressure liquid DEAE ion-exchange chromatography and hydroxyapatite columns, which revealed a single band of 14 kDa by SDS-PAGE. Rabbit anti-serum against the purified SF inhibited the immunosuppression induced by SE of C. ochracea with the recovery of lymphocyte proliferation.
Introduction
The genus Capnocytophaga is part of the normal oral microflora found in the absence of oral disease [l] . Capnocytophaga spp. frequently have been isolated in large numbers from peiodontal lesions of patients with localised juvenile periodontitis and other forms of periodontal disease [2- 41. An animal study with Capnocytophaga-mono-infected animals has clearly revealed its periodontopathic potential [5] .
Dental plaque is extremely dense in bacterial cell content because of frequent interbacterial aggregations [ 61. C. ochracea exhibits co-aggregation mediated by lectin-carbohydrate interaction. Furthermore, co-aggregated bacterial cells exhibit resistance to phagocytosis and the bactericidal action of polymorphonuclear leucocytes (PMNLs) [7] . As Capnocytophaga spp. can colonise periodontal pockets and possibly invade the surrounding tissue, investigation of the organism's ability to resist host defences is important for an understanding of the bacterial aetiology of periodontal disease and other infections. Capnocytophaga spp. also have the ability to inhibit the proliferation of human fibroblasts and promote the release of lysosomal enzyme from PMNLs, that contribute to the infection and the Several investigators have reported that some periodontopathic bacteria can suppress immune responses [18] . However, there is little information on the pathogenic potential of immunosuppressive substances in any periodontal disease.
Studies in this laboratory have investigated the immunoadjuvant effects of periodontopathic bacteria and the kinetics and the immunological role of immunosuppressive factor (SF) produced by these bacteria [ 191. Previous reports showed that A. actinomycetemcomitans produces a low mol. wt SF and that it affects CD4/CD8 ratios and cytokine production . The sonic extract (SE) from the cytoplasmic soluble fraction from C. ochracea also suppresses immunoglobulin production and causes a CD4/CD8 ratio disorder [23] . In the present study the SF from the cytoplasmic soluble fraction of C. ochracea was purified by extensive colunin chromatography and examined for the suppression of proliferation of murine spleen cells.
Materials and methods

Bacterial strains and growth conditions
C. ochracea ATCC 33563 and C. sputigena ATCC 33 123 were obtained from the American Type Culture Collection (Rockville, MD, USA). Porphyromonas gingivalis FDC 381 was also employed as a representative strain of periodontopathic bacteria in this study. The cells were grown in Brain Heart Infusion (BHI) Broth (Difco) supplemented with haemin 5 pg/ml and menadione 0.4 pg/ml in an anaerobic system (Model 1024, Forma Scientific, Marietta, OH, USA) for 2 days.
SE preparation
Micro-organisms were harvested by centrifugation (10 000 g), then washed three times with phosphatebuffered saline (PBS, pH 7.2). SE from the harvested bacterial cells was prepared by a method reported previously [ 191. Briefly, the bacterial cells were resuspended in PBS and sonicated for 45 min on ice with a sonicator (Ohtake Works, Tokyo, Japan). Disruption of the bacteria was confirmed by microscopy. The samples were centrifuged at 8000 g for 30 min, and the cell-free supernate was stored at -20°C until used for the experiments. The protein concentrations in the SE were estimated with the BioRad protein assay (BioRad, Richmond, CA, USA). The following SE preparation was also employed for some experiments: SE in 50 mM potassium phosphate buffer (pH 7.2) was heated for 10min at 100°C or treated with pronase E (Kaken Kogyo Ltd, Tokyo, Japan) for 24 h at 37°C. After treatment, the preparations were dialysed against distilled water. Polymixin B (Sigma)-treated SE (37"C, 30 min) was also prepared to study the effect of lipopolysaccharides (LPS) in SE.
Mice
C3H/HeN mice aged 7-8 weeks were obtained from Shizuoka Experimental (Hamamatsu, Japan) and LPSlow responder C3H/HeJ mice were obtained from Nihon-Clea (Tokyo, Japan). These mice were maintained in horizontal laminar flow cabinets and provided with sterile food and water ad libitum and were used at 8-9 weeks of age.
Proliferation assay
Spleen cells from C3H/HeN mice were washed and resuspended in RPMI 1640 supplemented with fetal calf serum 5%, 2.0 mM L-glutamhe, kanamycin 0.2 mg/ml and 15 mM N-2-hydroxyethylpiperazine-N-2-ethansulphonic acid (HEPES) buffer (pH 7.2), and adjusted to 3.5 X lo6 viable cells/ml before culture.
Lymphoid cells were cultured in triplicate in a 96-well microculture plate in a total volume of 0.2 ml of medium containing either Con A (Sigma) 0.5 pg or LPS (Sigma) 1.0 pg. Different concentrations of SE were added to these samples and cells were incubated for 72 h at 37°C in humidified air containing CO2 5%. Cultures were pulsed with 3.7 kBy of [3H]thymidine ( [3H]TdR, Amersham, Buckinghamshire) during the final 6 h of the inoculation. After the labelling period, cells were harvested on to glass fibre filters with a multiple-cell harvester type MHCMO-YR 1 162 (Biotec, Tokyo, Japan). The filters were dried, placed in vials with scintillation fluid and analysed with a scintillation counter (type LSC-6 73, Aloka, Tokyo, Japan). Each assay was repeated at least three times.
Extraction of LPS
Phenol-water-extracted LPS and butanol-water-extracted LPS were also prepared by the methods described previously [24, 25] . Briefly, lyophilised cells (10 g) were suspended in pyrogen-free water and phenol 90%. The mixture was stirred vigorously at 65°C for 20 min and then centrifuged at 7000 g for 20min. The aqueous phase was removed, and the phenol phase and insoluble precipitate were reextracted with water. The aqueous phase was dialysed extensively against distilled water, lyophilised and termed PW-LPS. The same weight of lyophilised cells was suspended in NaCl 0.85% in water. An equal volume of water-saturated butanol was added, and the aqueous phase was obtained after stirring the reaction mixture and centrifugation. The combined extracts of the aqueous phase were dialysed against distilled water and lyophilised. This was termed RW-LPS.
Preparation of fractions from bacterial cells
Cells of each strain (wet weight 17.5 g) were resuspended in PBS and homogenissd with glass beads (0.10-0.1 1 mm, 40 g) in a Braun cell homogeniser (Model MSK, B Braun, Germany). Samples were kept standing at room temperature for 10 min; suspensions were then centrifuged at 8000 g for 20min. Each supemate was obtained as a cytoplasmic fraction (CPF) after centrifugation at 100000 g for 60 min and dialysis against distilled water followed by lyophilisation. The precipitate was resuspended in 0.05 M phosphate buffer (pH 7.0) and stirred for 30 rnin at room temperature with the addition of an equal amount of buffer containing n-lauroylsarcosjne (N-dodecanol-N methylglycine) 2%. The supernate was obtained by centrifugation as described above. This was termed the inner membrane fraction (IMF) after dialysis against distilled water and lyophilisation.
Purification of SF
To prepare the cytoplasmic fraction, the homogenised fraction was .further centrifuged at 100 000 g for 60 min. The supernates containing cytoplasm were dialysed extensively against 20 mM Tris buffer (pH 8.2). The CPF from C. ochracea was dialysed against 10 mM Tris buffer (pH 7.4) and concentrated ( X 10) by Centricon 10 (Amicon, Lexington, MA, USA) and applied to an Ultrogel-AcA34 column, 6 X 40 cm, (IBF Biotechnics, France) pre-equilibrated with the same buffer. The column was then washed extensively. Tenml fractions were collected and monitored for UV absorbance and immunosuppressive activity (reduction of mitogen-induced [3H] TdR incorporation by LPS). Active fractions were pooled, dialysed against 10 mM Tris buffer (pH 7.4) and then applied to an HPLC-DEAE 5PW (Toso, Tokyo, Japan) column pre-equilibrated in the same buffer. The column was then extensively washed and eluted with a linear NaCl gradient (0-0.5 M). Active fractions were pooled, concentrated by membrane filtration (Centricon 10; Amicon) and applied to an HPLC-hydroxyapatite-MP column, 8.8 X 10 cm, (Kanto Chemical, Tokyo, Japan). The column was washed extensively with the same buffer and eluted with a linear KH2P04---K*HP04 gradient (0-0.5 M). Active immunosuppressive fiactions were pooled and concentrated after dialysis.
SDS-PAGE
Samples at each step in the purification procedure were examined by SDS-PAGE. Samples were loaded at concentrations of 10-50 pg of protein/lane. Electrophoresis was performed at 15 mA for 60 min with resolving 15% and stacking 4% gels. Proteins were stained with Coomassie Brilliant Blue R-250. A low mo1.-wt standard (BioRad) was used for the mol.wt estimate. The periodic acid-Schiff base method was also used for determination of the homogeneity of SF.
Enzyme and heat treatments of SF
The purified SF (4.0 pg) in 50 mM potassium phosphate buffer (pH 7.2) was heated for 10 min at 100°C. Pronase sensitivity was also tested by incubation of SF with pronase E (Kaken Kogyo) at 37°C for 2 h. The enzyme was inactivated by heating for 10 min at 100°C. After treatment, the preparation was dialysed against distilled water at 4°C. The samples were tested with a mitogen-induced proliferation assay with mouse spleen cells.
Preparation of anti-SF serum
Three New Zealand White rabbits (Shizuoka Experimental, Hamamatsu, Japan) were given four subcutaneous injections with 0.1 ml of a 1:l emulsion mixture of purified SF from C. ochracea and complete Freund's adjuvant (Difco) on days 0 and 14. On day 28, rabbits were boosted with an inter-muscular injection of antigen. A total of 500 pg of purified SF was given to each rabbit. Serological analysis of various antigens with rabbit anti-SF serum was done by Western blotting. Anti-SF serum was obtained from these rabbits and assayed for its inhibitory action on immunosuppression against SE.
Western blotting
Antigen preparations were transferred electrophoretically to a nitrocellulose filter after SDS-PAGE separation [26] . The filter was soaked in 50 mM Tris-HC1 buffer (pH 7.3) containing 0.15 M NaCl and low-fat milk 5% and shaken gently for 30 min. The strips of nitrocellulose filter were incubated with antiserum for 4 h at room temperature. After washing and blocking, the membrane was incubated with a solution of horseradish peroxidase-conjugated anti-rabbit IgG mouse monoclonal antibody (Zymed Laboratories, San Francisco, CA, USA), followed by incubation in a solution containing 4-chloro-naphthol 0.05%.
Statistical analysis
Statistical analysis was performed with Student's t test.
Results
Effect of SE on mitogen
SEs of tested bacteria were first examined for their ability to alter mitogen-induced spleen cell proliferation as shown in Fig. 1A and B. A low concentration (5 pg/well) of the SE from P gingivalis enhanced cell proliferation induced by Con A or LPS. However, a high concentration (20-40 pglwell) caused a dosedependent inhibition. Two strains of Capnocytophaga revealed a strong immunomodulative activity, even at low concentrations. In particular, C. ochracea demonstrated maximum inhibition on mitogen-induced proliferation at 5-10 pg/well. The addition of this SE (5 pglwell) inhibited 65.2% of mitogenic effect of Con A and 75.1% of LPS. Moreover, the addition of 10 pglwell and 20 pglwell inhibited 90.4% and 99.2% of the proliferation induced by Con A and LPS, respectively. The effect of incubation time with SE on the proliferation of spleen cells was also examined. Pre-incubation with SE (1 -6 h) strongly inhibited the proliferation induced by LPS (data not shown). However, pre-incubation with SE did not affect the survival ratio of spleen cells which was examined by the trypan blue exclusion method (survival ratio of pre-exposed cells > 95.3%). Therefore, the maximum inhibition dose (20 pg) of SE and pre-incubation of SE and the cells for 1 h was selected for the following experiments.
As it was important to determine which components in SE induced suppression, two strains of Capnocytophaga that had demonstrated strong immunosuppression were selected to elucidate what the effective components in the SEs were. The heat-and pronasetreated SEs were employed in these series of Fig. 2A and B) . The mitogen-induced proliferation was restored to various degrees by these treatments; heat-treatment of SE from C. ochracea produced recovery of up to 78.2% (Con A) and 90.4% (LPS) of the control, and with pronase-treatment, 85.1% (Con A) and 80.3% (LPS) ( Fig. 2A and B) . Similar recoveries were obtained for SE from C. sputigena. Spleen cells from LPS-low responder mice, C3H/HeJ, were also used to examine the inhibitory effect of native SE from two strains of Capnocytophaga employing the same procedure as above. Similar results were obtained with C3H/HeN mice (Fig. 3) . SEs from strains of Capnocytophaga produced a strong suppression of 95.1-99.0% of the control, respectively, for both mitogens. Polymixin B (an LPS inhibitor) was used to elucidate the effect of LPS in SE. Polymixin B did not affect the suppression induced by these strains under the conditions of the reaction mixture containing SE (20 pg) and different concentrations of polymixin B (0.2-2.0 pg) (data not shown).
Suppressive effect of prepared fractions
Four different fractions were prepared from C. ochracea which strongly suppressed Con A-and LPSinduced cell proliferation ( Fig. 4A and B) . PW-LPS restored by either heat or pronase treatment of this CPF (data not shown). These data suggest that SF from CPF of C. ochracea was at least proteinaceous in part.
Purification of SF
SF from CPF was purified by a combination of gelfiltration and HPLC-DEAE. As shown in Fig. 5B , the immunosuppressive fraction was obtained as a sharp peak. However, as several other bands were detected in this sample by SDS-PAGE (Fig. 6, lane D) , the concentrated active fraction was further applied to a hydroxyapatite-MP column and eluted with elution buffer. SF fractions were purified by hydroxyapatite-MP column and then subjected to SDS-PAGE analysis. This clearly revealed one band that corresponded to a mol. wt of c. 14 kDa by Coomassie Brilliant Blue R-25 staining (Fig. 6, lane E) . SF did not display any bands, as tested for the PAS method (data not shown). When this SF was examined for activity, ID50 was 16.7 ng for LPS stimulation and 25.0 ng for Con A.
Inhibition of immunosuppressive activity of SF by rabbit anti-SF serum
The results of Western blotting showed that the rabbit anti-SF serum revealed a single band which was identical with SF in the lane of the DEAE-5PW preparation (Fig. 6, lane F) . A difference was found in the serum titre. Therefore, the serum that possessed the highest titre was employed in the assay for inhibition of immunosuppressive activity of SF by rabbit anti-SF serum. This was examined by the proliferation assay system, stimulated with LPS. The addition of diluted anti-serum (1 in 100, 1 in 500) inhibited SE-induced immunosuppression 96.7% and 89.2%, and SF-induced immunosuppression 98.2% and 96.4%, respectively.
Characterisation of SF
The heat-and pronase-treated SF was employed in this study. The mitogen-induced proliferation was restored to various degrees by these treatments; heat treatment of SF produced recovery of up to 92.3% (Con A) and 97.6% (LPS) of the control, with pronase treatment producing recovery to 94.2% (Con A) and 98.1% (LPS).
Discussion
The Capnocytophaga spp. tested suppressed murine lymphocyte proliferative responses to mitogens with low amounts of SE (Fig. 1) . In particular, C. ochracea revealed a strong immunosuppressive effect on the cell proliferation of murine spleen cells. The SF was purified from CPF by a column chromatography technique. At the first stage of the experiment, the suppressive activity of SE from C. ochracea decreased or was destroyed by either heat or pronase treatment ( Fig. 2) . After the purification procedure, SDS-PAGE analysis revealed that SF migrated as a single band corresponding to a molecular mass of 14 kDa. This molecule was protease and heat sensitive. The data clearly indicate that immunosuppression induced by SF from C. ochracea may be attributable to proteinaceous components. However, other components in SE, such as LPS, may contribute to the immunosuppression. Therefore, the following experiments were performed. LPS low responder C3H/HeJ mice were employed to clarify the participation of LPS in this suppression. Complete inhibition of cellular proliferation induced by either Con A or LPS was also found in C3H/HeJ mice (Fig.  3) . Moreover, no immunomodulative activity was observed in experiments with two different preparations of LPS (PW-LPS and BW-LPS extracted from Cupnocytophugu strains; Fig. 4A and B) . Generally LPS demonstrates strong immunomodulative and biological activities [27] . Mixtures of different concentrations of polymixin B with SE did not inhibit suppressive activity (data not shown). The data clearly indicated that LPS of Capnocytophaga strains did not have any pathogenic potential in tests for various biological activities. A previous study also reported that LPS isolated from Capnocytophaga spp. did not have any pathogenic features [28] .
It has been shown previously that the suppressive effect on the murine lymphocyte mitogenic response was caused by the exopolysaccharide from C. ochracea [29, 30] . Gormand et al. [17] reported similar inhibition of lymphocyte response to these mitogens, and the inhibition was more potent with bacterial suspension than supernate. The SF described here was located in the CPF of C. ochracea, suggesting that the cytoplasmic SF remained intracellular and that the bacterial suspension contained a sufficient amount of SF to inhibit lymphocyte proliferation.
Purified T or B cells were not employed in this study. Therefore, the respective effect of SF on each subset of lymphocytes cannot be explained from these data. However, pre-incubation with SF and splenic cells revealed different cell proliferation induced by Con A and LPS (data not shown). A decrease of CD4/CD8 ratio and lymphocyte proliferation induced by Con A has been reported in an endocarditis patient with C. ochracea [17] and IL-2 receptor expression and Con A-induced proliferation of peripheral blood mononuclear cells were decreased during C. ochracea infection. Differences in response to mitogens and clinical aspects involving lymphocytes may suggest that disorder of a specific lymphocyte subset results in immunosuppression.
A . actinomycetemcornitans has been a suspected aetiological agent in localised juvenile and adult periodontitis, demonstrating a variety of virulence factors in in-vitro experiments. It can also cause disease such as bacterial endocarditis, meningitis, septicaemia and abscesses in extra-oral sites [ 12, 131. A . actinomycetemcomitans produces a protease-labile, non-cytotoxic low mol. wt (14 kDa) suppressive factor [22] . Previous studies have shown that priming with a high concentration of SE from A . actinomycetemcomitans induced an immunosuppressive effect on immunoglobulin production, CD4/CD8 ratios and blastogenic activity to mitogen . This inhibitory mechanism was, in part, clarified by the demonstration of suppression of IL-2 synthesis, IL-2 receptor expression and IL-6 secretion [20, 21] . Finally, A . actinomycetemcomitans produced the development of humoral or cell-mediated immune responses, or both, via the modulation of the T-cell subset and cytokine production. The evidence found in A. actinomycetemcomitans infection indicates the possibility that similar mechanisms may exist in capnocytophaga infection.
Some of the recent cases of bacteraemia have originated from the oropharynx, although the gastrointestinal tract has been the most common source of bacteraemia [3 1-33] . The high frequency of systemic infection due to C. ochracea suggests that periodontal disease has to be considered as a possible precursor of systemic infection. It may be said that the classic source of bacteraemia in compromised or noncompromised patients, i.e., colonic microflora, appears to have been replaced by oral microflora in the anaerobic-capnophilic bacteraemias. Furthermore, another problem of concern in capnocytophaga infection is that strongly P-lactamase-positive Capnocytophaga strains have been isolated from the patients [34, 351. This study has demonstrated that C. ochracea produces a proteinaceous inhibitory factor. The intracellular SF and exopolysaccharide may affect the host defence system by their combined actions both locally and systemically. Therefore, studies on the effect of SF as immunosuppressive treatment in capnocytophaga infection would be of great interest. The exact kinetics and immunological role of purified SF on the human immune system require further study.
